UK's CMA says Illumina-Pacific Biosciences deal could hurt competition
June 18, 2019 at 06:27 AM EDT
Britain's competition watchdog said on Tuesday the planned $1.2 billion merger between gene sequencing company Illumina Inc and smaller rival Pacific Biosciences of California Inc may result in lessening of competition in the UK.
